glp-1 for crohn's The role of RA in inflammatory bowel disease. The GLP-1 RA Tirzepatide and Crohn's Disease: Safety

Staphylococcus aureus , one of the earliest and most persistent pathogens found in the lungs of people with CF, has been shown to adapt to the lung environment by increasing pro-inflammatory cytokine secretion (e.g., TNF- or IL-8, involved in the mucin secretion pathway) through upregulating staphylococcal protein A (Spa) (Ramond et al., 2022)

Anti-aging clinics are charging thousands for peptide therapy

Nutrients, 15(3), 729

Mounjaro (tirzepatide) and Ozempic (semaglutide) are both GLP-1 receptor agonists, but tirzepatide adds a second mechanismGIP receptor activationthat changes how doses compare

By comparison, semaglutide plateaued around 14.9% and tirzepatide around 22.5% during active treatment in the data ASMBS reviewed, which will be much lower (maybe even close to zero) whenever we are able to get 10 year data on these patients, as few will be able to continue treatment for 10 years

However, there are a few caveats worth noting